Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of
Primary Endpoint Per Protocol Analysis, and Exploratory Endpoints
- Jonathan Bernstein
, - Umesh Singh,
- Marepalli Rao,
- Karen Berendts,
- Xiang Zhang,
- Diya Mutasim
Jonathan Bernstein
University of Cincinnati
Corresponding Author:bernstja@ucmail.uc.edu
Author ProfileMarepalli Rao
University of Cincinnati College of Medicine
Author ProfileDiya Mutasim
University of Cincinnati College of Medicine
Author Profile26 Oct 2020Submitted to Allergy 27 Oct 2020Submission Checks Completed
27 Oct 2020Assigned to Editor
29 Oct 2020Reviewer(s) Assigned
15 Nov 2020Review(s) Completed, Editorial Evaluation Pending
29 Nov 20201st Revision Received
30 Nov 2020Submission Checks Completed
30 Nov 2020Assigned to Editor
01 Dec 2020Reviewer(s) Assigned
10 Dec 2020Review(s) Completed, Editorial Evaluation Pending
10 Dec 2020Editorial Decision: Accept
